• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Extracorporeal CPR and conventional CPR similarly improve cardiac arrest survival

byDavid XiangandKiera Liblik
February 2, 2023
in Cardiology, Emergency
Reading Time: 3 mins read
Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest
Share on FacebookShare on Twitter

1. In patients with refractory out-of-hospital cardiac arrest, extracorporeal cardiopulmonary resuscitation (CPR) had comparable effects on survival compared to conventional CPR. 

2. Extracorporeal CPR and conventional CPR also had similar effects on survival with a favorable neurologic outcome in patients with refractory out-of-hospital cardiac arrest.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Early initiation of basic life support, high-quality chest compressions, and external defibrillation are crucial steps for managing out-of-hospital cardiac arrest. However, when these measures fail, the chance of survival with CPR declines rapidly over time. Extracorporeal CPR, the addition of extracorporeal membrane oxygenation to standard advanced cardiac life support, has been proposed to restore perfusion with the goal of limiting hypoxic brain injury and allowing for increased treatment of the underlying cause of cardiac arrest. However, there is a gap in knowledge as to understanding the effect of extracorporeal CPR on survival and neurologic outcomes as compared to conventional CPR in patients with refractory out-of-hospital cardiac arrest and initial ventricular arrhythmia. Overall, this study found that extracorporeal CPR and conventional CPR had similar effects on survival with a favorable neurologic outcome at 30 days in patients with refractory out-of-hospital cardiac arrest caused by an initial ventricular arrhythmia. This study was limited by early randomization which led to a considerable number of patients who had a return of spontaneous circulation between random assignment and hospital arrival, as well as crossovers by three patients who died despite receiving extracorporeal CPR. Nevertheless, these study’s findings are significant, as they demonstrate that extracorporeal CPR and conventional CPR have similar outcomes with regard to survival and neurologic outcomes in patients with out-of-hospital cardiac arrests.

Click to read the study in NEJM

Relevant Reading: Therapeutic Hypothermia after Out-of-Hospital Cardiac Arrest in Children

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

In-Depth [randomized controlled trial]: This multicenter, randomized controlled trial was conducted in the Netherlands. Patients who were 18 to 70 years of age who had a witnessed, refractory out-of-hospital cardiac arrest with an initial ventricular arrhythmia (either ventricular fibrillation or ventricular tachycardia or a shockable rhythm detected by an automated external defibrillator) were eligible for the study. Patients who had a return of spontaneous circulation with sustained hemodynamic recovery within 15 minutes, terminal heart failure (New York Heart Association class III or IV), severe pulmonary disease (grade III or IV on the Chronic Obstructive Pulmonary Disease Global Initiative for Obstructive Lung Disease criteria), disseminated oncologic disease, obvious or suspected pregnancy, bilateral femoral bypass surgery, known contraindications for extracorporeal CPR, known advance health-care directive prohibiting resuscitation or invasive ventilation, and expected time interval of more than 60 minutes between the initial cardiac arrest to the initiation of the cannulation procedure were excluded from the study. The primary outcome measured was survival with a favorable neurologic outcome. Outcomes in the primary analysis were assessed via an intention-to-treat basis with a mixed logistic model. Based on the primary analysis at 30 days, 14 patients (20%) in the extracorporeal CPR group were alive with a favorable neurologic outcome, as compared with 10 patients (16%) in the conventional CPR group (odds ratio, 1.4; 95% confidence interval, 0.5 to 3.5), with the number of adverse events in each group similar (p>0.05). Overall, this study demonstrated that extracorporeal CPR and conventional CPR have similar effects on survival with a favorable neurologic outcome in patients with refractory out-of-hospital cardiac arrest.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiac arrestcardiologycardiopulmonary resuscitation (CPR)cpremergencyout-of-hospital cardiac arrest (OHCA)ventricular fibrillationventricular tachycardia
Previous Post

Wellness Check: Exercise

Next Post

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post
CPAP may not decrease cardiovascular events in sleep apnea

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

Quick Take: Association of African Ancestry with Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study

Mavacamten associated with improvement in submaximal exertional tolerance: A secondary analysis of the EXPLORER-HCM randomized trial

Nonleg venous thromboses associated with PE, longer ICU stay

Efanesoctocog alfa is efficacious in treating severe hemophilia A

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.